2/10
08:03 am
pasg
Passage Bio (NASDAQ:PASG) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Low
Report
Passage Bio (NASDAQ:PASG) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.